• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不规则颗粒形态和粉末性质的描述符。

Descriptors of irregular particle morphology and powder properties.

作者信息

Concessio NM, Hickey AJ

机构信息

School of Pharmacy, University of North Carolina, Beard Hall, CB#7360, Chapel Hill, NC 27599-7360, USA

出版信息

Adv Drug Deliv Rev. 1997 Jun 9;26(1):29-40. doi: 10.1016/s0169-409x(97)00508-5.

DOI:10.1016/s0169-409x(97)00508-5
PMID:10837530
Abstract

The description of irregular particle morphology and powder properties may offer unique insights into the performance of materials intended for use in dry powder inhalers. A number of mathematically similar approaches have been used to study these phenomena, all based on evaluating data in terms of irregular oscillations around a mean value. The specific methods described are Fourier, fractal and chaos analysis, stochastic and percolation models. Data describing the morphology of disodium cromoglycate particles, the behaviour of lactose and sodium chloride powders and dispersion of Intal((R)) (disodium cromoglycate/lactose blend) utilizing a Spinhaler((R)) is presented to demonstrate the application of these approaches to dry powder inhaler systems. It is envisaged that these techniques may be used to characterize powders with a view to guiding formulation and that ultimately this may lead to a greater understanding of the nature and magnitude of performance variables.

摘要

对不规则颗粒形态和粉末性质的描述可能为用于干粉吸入器的材料性能提供独特的见解。已使用多种数学上相似的方法来研究这些现象,所有这些方法均基于围绕平均值的不规则振荡来评估数据。所描述的具体方法包括傅里叶分析、分形分析和混沌分析、随机模型和渗流模型。本文展示了描述色甘酸钠颗粒形态、乳糖和氯化钠粉末行为以及使用Spinhaler®(色甘酸钠/乳糖混合物)的Intal®分散情况的数据,以证明这些方法在干粉吸入器系统中的应用。预计这些技术可用于表征粉末,以指导配方设计,最终可能有助于更深入地了解性能变量的性质和大小。

相似文献

1
Descriptors of irregular particle morphology and powder properties.不规则颗粒形态和粉末性质的描述符。
Adv Drug Deliv Rev. 1997 Jun 9;26(1):29-40. doi: 10.1016/s0169-409x(97)00508-5.
2
Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.CFD 结合拉格朗日粒子追踪在干粉吸入器中应用的潜力和限制。
Eur J Pharm Sci. 2019 Feb 1;128:299-324. doi: 10.1016/j.ejps.2018.12.008. Epub 2018 Dec 14.
3
Dry powders for oral inhalation free of lactose carrier particles.不含乳糖载体颗粒的干粉吸入剂。
Adv Drug Deliv Rev. 2014 Aug;75:32-52. doi: 10.1016/j.addr.2014.04.005. Epub 2014 Apr 13.
4
Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.用于改善丙酸氟替卡松干粉吸入器性能的表面改性乳糖颗粒的制备与评价
J Aerosol Med Pulm Drug Deliv. 2015 Aug;28(4):254-67. doi: 10.1089/jamp.2014.1146. Epub 2014 Dec 17.
5
Powder dispersion mechanisms within a dry powder inhaler using microscale particle image velocimetry.利用微尺度颗粒图像测速技术研究干粉吸入器内的粉末分散机制。
Int J Pharm. 2016 Dec 5;514(2):445-455. doi: 10.1016/j.ijpharm.2016.07.040. Epub 2016 Aug 4.
6
Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics.干粉吸入器中所含组分颗粒的物理特性。II. 动态特性。
J Pharm Sci. 2007 May;96(5):1302-19. doi: 10.1002/jps.20943.
7
Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders.颗粒大小、气流及吸入装置对色甘酸钠粉末雾化的影响。
Int J Pharm. 2000 Sep 25;206(1-2):75-83. doi: 10.1016/s0378-5173(00)00516-0.
8
Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.保护疏水性氨基酸,防止高吸湿性喷雾干燥粉末的雾化性能因水分引起的劣化。
Eur J Pharm Biopharm. 2017 Oct;119:224-234. doi: 10.1016/j.ejpb.2017.06.023. Epub 2017 Jun 24.
9
Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.用标准夹带管从含有一水乳糖的药物混合物中产生的干粉气雾剂:1. 硫酸沙丁胺醇和二钠色甘酸钠。
J Pharm Sci. 2010 Aug;99(8):3398-414. doi: 10.1002/jps.22107.
10
Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development.粉末透气度:干粉吸入器制剂开发的潜在工具。
Eur J Pharm Biopharm. 2010 Nov;76(3):464-9. doi: 10.1016/j.ejpb.2010.09.003. Epub 2010 Sep 18.

引用本文的文献

1
Deposition Pattern of Polydisperse Dry Powders in Andersen Cascade Impactor - Aerodynamic Assessment for Inhalation Experimentally and .多分散性干粉在安德森级联撞击器中的沉积模式——吸入的空气动力学实验评估及…… (原文结尾不完整)
Turk J Pharm Sci. 2020 Feb;17(1):20-26. doi: 10.4274/tjps.galenos.2018.15870. Epub 2020 Feb 19.
2
Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations.聚己内酯微球粒径对硫酸沙丁胺醇干粉吸入剂制剂分散效果的研究。
Pharm Res. 2012 Sep;29(9):2445-55. doi: 10.1007/s11095-012-0772-y. Epub 2012 May 15.
3
Immunization by a bacterial aerosol.
通过细菌气溶胶进行免疫接种。
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4656-60. doi: 10.1073/pnas.0800043105. Epub 2008 Mar 14.
4
Pharmaceutical dry powder aerosols: correlation of powder properties with dose delivery and implications for pharmacodynamic effect.药物干粉气雾剂:粉末性质与剂量递送的相关性及其对药效学效应的影响
Pharm Res. 1999 Jun;16(6):828-34. doi: 10.1023/a:1018865717374.